Document is current
Any future updates will be listed below
-
Authors
Singh, Megha https://orcid.org/0000-0003-3680-7124
Fayaz, Fathima Fazla Ahamed https://orcid.org/0000-0003-0788-6492
Wang, Jingya https://orcid.org/0000-0003-1498-2693
Wambua, Steven https://orcid.org/0000-0003-2300-7670
Subramanian, Anuradha https://orcid.org/0000-0001-8875-7363
Reynolds, John A. https://orcid.org/0000-0002-8962-4404
Nirantharakumar, Krishnarajah https://orcid.org/0000-0002-6816-1279
Crowe, Francesca https://orcid.org/0000-0003-4026-1726
,
-
Funding
Funding for this research was provided by:
MRC (MR/W014432/1, MR/W014432/1, MR/W014432/1, MR/W014432/1)
- License Information
-
More Information
Article History
Received: 17 April 2024
Accepted: 29 July 2024
First Online: 26 August 2024
Declarations
:
: Since this review analyses the data from the prior systematic reviews, no ethical approval is required. Consent to participate is not applicable.
: Not applicable.
: Co-author AS was part of university of Birmingham when this review was initiated but moved to work with Astrazeneca. She currently holds an honorary contract with the University of Birmingham. All the other authors declare that they have no competing interests.
